Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.

ABSTRACT:

Objective

Autoimmune pancreatitis (AIP) is a treatable form of chronic pancreatitis that has been increasingly recognised over the last decade. We set out to better understand the current burden of AIP at several academic institutions diagnosed using the International Consensus Diagnostic Criteria, and to describe long-term outcomes, including organs involved, treatments, relapse frequency and long-term sequelae.

Design

23 institutions from 10 different countries participated in this multinational analysis. A total of 1064 patients meeting the International Consensus Diagnostic Criteria for type 1 (n=978) or type 2 (n=86) AIP were included. Data regarding treatments, relapses and sequelae were obtained.

Results

The majority of patients with type 1 (99%) and type 2 (92

SUBMITTER: Hart PA 

PROVIDER: S-EPMC3862979 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature